Urma Estima plictiseală programme teva 19 aout 2018 a da foc citesc o carte Cordelia
Programme TV du Dimanche 19 août : notre sélection - Le Parisien
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease | Neurology
Teva secures FDA approval for Ajovy to prevent migraine episodes
Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial - The Lancet Neurology
JPM | Free Full-Text | Impact of the COVID-19 Pandemic on the Epidemiological Situation of Pulmonary Tuberculosis–Using Natural Language Processing
Proxy-analysis of the genetics of cognitive decline in Parkinson's disease through polygenic scores | npj Parkinson's Disease
Antibiotics | Free Full-Text | Vaccination against Community-Acquired Pneumonia in Spanish Adults: Practical Recommendations by the NeumoExperts Prevention Group
Latino Leaders May - June by Latino Leaders - Issuu
IJERPH | Free Full-Text | Protocol for the Implementation and Assessment of “MoodUP”: A Stepped Care Model Assisted by a Digital Platform to Accelerate Access to Mental Health Care for Cancer Patients
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease | npj Parkinson's Disease
Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data - The Lancet
Pipeline - Tarsier® Pharma
PharmaBoardroom - TEVA
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations - The Lancet Respiratory Medicine
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2
iPS-cell-derived microglia promote brain organoid maturation via cholesterol transfer | Nature
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials | Neurology